Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Observational Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh

NCT04434144 is registered in ClinicalTrials.gov with Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar as lead sponsor.

NCT NCT04434144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04434144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Observational Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh
Lead sponsor
Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar
Phase
Observational
Overall status
Completed
Start date
May 2, 2020
Completion date
June 5, 2020
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, hydroxychloroquine, ivermectin